Latest News
In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a pioneer in AI-driven clinical research, for a staggering $47.8 billion. The deal represents the largest "Tech-Bio" merger in
Via MarketMinute · April 6, 2026
The global energy landscape reached a perilous tipping point today, April 6, 2026, as oil prices surged following a total naval blockade of the Strait of Hormuz by Iran’s Islamic Revolutionary Guard Corps (IRGC). West Texas Intermediate (WTI) crude settled at $112.41 per barrel, an increase of nearly
Via MarketMinute · April 6, 2026
The U.S. economy faced a jarring reality check this week as the Institute for Supply Management (ISM) released its March 2026 Services PMI report. While the headline figure showed a sector still in expansion, the underlying data sent shockwaves through Wall Street. The headline PMI came in at 54.
Via MarketMinute · April 6, 2026
On April 6, 2026, Jamie Dimon, the Chairman and CEO of JPMorgan Chase & Co. (NYSE: JPM), released his highly anticipated annual letter to shareholders, delivering a sobering assessment of the global financial landscape. While the U.S. economy has displayed remarkable resilience over the past year, Dimon’s 2026 missive
Via MarketMinute · April 6, 2026
The U.S. stock market staged a modest advance on Monday, as investors grappled with a high-stakes geopolitical standoff in the Middle East. The S&P 500 rose 0.4% to finish at 6,611.83, a cautious gain that reflected a "wait-and-see" approach on Wall Street. Despite the positive
Via MarketMinute · April 6, 2026
These three TSX dividend stocks offer yields above 5% and solid fundamentals to match.
Via The Motley Fool · April 6, 2026
Investors should consider building a position over time in this Canadian stock that's a worthy long-term core holding.
Via The Motley Fool · April 6, 2026

A shift in strategy dating back several years could pay off big time for Uber down the road.
Via The Motley Fool · April 6, 2026
C3.ai, Inc. (NYSE: AI), a key player in the enterprise artificial intelligence (AI) software market, has faced considerable market headwinds throughout 2026. C3.ai’s stock price has reflected these challenges, trending steadily downward to trade near its 52-week lows. For many observers, the narrative appears straightforwardly bearish, shaped by recent financial performance and broad market sentiment in the highly volatile AI sector.
Via MarketBeat · April 6, 2026
It's being acquired by a peer.
Via The Motley Fool · April 6, 2026
The iShares S&P/TSX Capped Composite Index Fund (TSX:XIC) is a quality TFSA asset to hold.
Via The Motley Fool · April 6, 2026
Even with $400, you can start building passive income with this dependable TSX stock.
Via The Motley Fool · April 6, 2026

Brookfield stock is a good growth idea to consider for long-term investors, given it has multiple megatrends to invest for growth.
Via The Motley Fool · April 6, 2026
These AI leaders are growing rapidly and doing so profitably.
Via The Motley Fool · April 6, 2026
Here are five TSX dividend stocks that offer stability, income, and long‑term durability for the next decade.
Via The Motley Fool · April 6, 2026

Here are three of the most defensive dividend stocks Canadian investors should be looking at right now, at least for those who value stability.
Via The Motley Fool · April 6, 2026
Oil prices rose as President Trump's deadline for Iran to open the Strait of Hormuz drew near. Tehran is letting more ships through, but it may not be enough.
Via Investor's Business Daily · April 6, 2026
Get insights into Canadian stocks that show promise for 2026. Find out which stocks are weathering economic challenges.
Via The Motley Fool · April 6, 2026
BCE stock is a reasonable consideration for above-average income.
Via The Motley Fool · April 6, 2026
It's not a good idea to limit yourself.
Via The Motley Fool · April 6, 2026

Aehr Test Systems is set to release its quarterly results tomorrow, and the stock is already seeing huge gains.
Via The Motley Fool · April 6, 2026
This biotech firm developing antibody therapies for rare diseases disclosed a significant insider sale amid rapid share price gains.
Via The Motley Fool · April 6, 2026
Even with lower rates, these two Canadian energy stocks look like strong buys.
Via The Motley Fool · April 6, 2026
Docebo’s sell-off looks more like market nerves than a broken business, and its profits and buybacks are making that gap harder to ignore.
Via The Motley Fool · April 6, 2026